Related Experiment Videos
[Propofol for sedation in gastroscopy--a randomized comparison with midazolam]
C Hofmann1, R Kiesslich, A Brackertz
1Innere Abteilung, St.-Hildegardis-Krankenhaus Mainz.
Zeitschrift Fur Gastroenterologie
|August 24, 1999
Summary
Propofol offers comparable sedation quality to midazolam for upper endoscopy, with a significantly faster recovery time. Continuous monitoring is advised due to potential blood pressure decreases with propofol.
Area of Science:
- Gastroenterology
- Anesthesiology
- Pharmacology
Background:
- Midazolam is a common choice for sedation during upper gastrointestinal endoscopy due to its amnestic and sedative properties.
- Propofol, a short-acting anesthetic, offers rapid onset sedation and amnesia, with potential hypnotic effects at higher doses.
Purpose of the Study:
- To compare the efficacy and safety of propofol versus midazolam for sedation during esophagogastroduodenoscopy (EGD) in a prospective randomized trial.
Main Methods:
- Sixty patients undergoing EGD were randomized to receive either propofol (n=30) or midazolam (n=30).
- Vital signs including blood pressure, oxygen saturation, and heart rate were continuously monitored.
- Sedation quality was assessed by both the endoscopist and the patient.
Main Results:
- No significant differences were observed in heart rate or oxygen saturation between the propofol and midazolam groups.
- Propofol administration resulted in a significant decrease in blood pressure (p < 0.01).
- Sedation quality was rated as good in both groups, with a significantly shorter recovery time for propofol (p < 0.01).
Conclusions:
- Propofol serves as a viable alternative for sedation in upper endoscopy, providing equivalent sedation quality to midazolam.
- The primary advantage of propofol is its significantly shorter recovery time post-procedure.
- Continuous patient monitoring is recommended when using propofol due to the risk of blood pressure reduction.